Business Wire

CS-GLOBAL-PARTNERS

Share
CS Global Partners: EY Says Citizenship is Independent of Tax Residency

The CBI Index has published a report compiled by top global tax advisors Ernst & Young (EY) that provides important insight on the distinction between citizenship and tax residency and debunks the myth that citizenship by investment (CBI) programmes, such as those operated by the Commonwealth of Dominica and St Kitts and Nevis, pose a risk to tax reporting.

Following an in-depth analysis, EY concludes that: (1) citizenship and tax residency are “distinct” concepts; (2) CBI programmes do not themselves facilitate tax evasion and incorrect reporting under the CRS; and (3) citizenship is not relevant to obtaining tax residency in Dominica, St Kitts and Nevis, or St Lucia,

These findings are significant, as they counter recent criticisms of CBI programmes made by bodies such as the OECD and the European Commission, which are largely based on the mistaken view that CBI programmes are, for all intents and purposes, vehicles for obtaining a new tax residency status.

EY surveys historical precedent and model international conventions to conclude that tax residency, as a concept, is “separate to that of citizenship.” Tax residency, it says, is “often built around the degree of personal socioeconomic links with a country,” and that a majority of tests, including those in the OECD Model Tax Convention, look to physical presence, a permanent home, a habitual abode, or a centre of vital interests to determine tax residency. “[R]eference to citizenship,” instead, “is rarely used as a tie-breaker in relation to residence.”

The report highlights CBI as an industry where the concept of tax benefits, tax residency, and citizenship are commonly – and erroneously – associated. Countries may offer both tax incentives and CBI options, but the two are separate. Indeed, the more common reasons for applying for citizenship are listed as political security, increased travel prospects, lifestyle advantages, and escape from prejudice.

The report finds support in the words of the OECD, which, in February 2018 said that CBI schemes “generally do not provide tax residence,” and of the European Commission, which, in January 2019, said “the use of these schemes does not equate to tax evasion.”

With respect to reporting tax information under the CRS, EY concludes that “citizenship should not give rise to tax avoidance and evasion opportunities, as the reporting rules [under the CRS] are explicit in not using citizenship as a test.” Per the CRS Implementation Handbook, “US specificities (such as the use of citizenship as an indicia of tax residence) […]” were removed from the CRS.

Caribbean CBI jurisdictions Dominica and St Kitts and Nevis are cited in EY’s report to illustrate how tax residency cannot be accessed by the mere fact of citizenship. In Dominica, the report shows that time spent on the island – not citizenship – is the rationale on which tax residency is based. In St Kitts and Nevis, a temporary resident is distinguished from a resident (who may be liable to certain tax) on the basis of periods spent in the Federation and purpose of stay. Of the Caribbean generally, EY says: “Whilst it may very well be common for a person to be a citizen (whether by birth or naturalisation) of the same jurisdiction in which he is resident, it is clear that citizenship is not a relevant determinant of [tax] residence […].”

In releasing its report, EY has provided much-needed commentary on the distinction between citizenship and tax residency, and, by consequence, on the independence of citizenship by investment from tax-related activities, such as reporting under the CRS.

Access the EY report here .

Contact:

Thomas Kohn pr@csglobalpartners.com +(44)2073184343 www.csglobalpartners.com

Link:

ClickThru

Social Media:

https://www.facebook.com/CSGlobalPartners/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba27.5.2025 17:46:00 CEST | Press release

Galderma Group AG (SWX:GALD): Ad hoc announcement pursuant to Art. 53 LR Galderma intends to repurchase approximately 2.4 million shares in the context of the accelerated bookbuild offering of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (“ADIA”) and Auba Investment Pte. Ltd. (“Auba”) announced today The repurchased shares will be held in treasury and financed by existing liquidity at hand Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it intends to repurchase approximately 2.4 million Galderma shares in the context of an accelerated bookbuilding offering (“ABO”) of approximately 16.7 million Galderma shares (approximately 7% of Galderma’s share capital) by EQT, ADIA and Auba. Galderma will participate in the ABO at the same price per share which will be determined in the bookbuilding. The repurchased shares will be financed by Galderma’s existing liquidity on hand and will not affect the company’s ability to de

New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical Trial Collaboration27.5.2025 17:44:00 CEST | Press release

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong, New South Wales (NSW) Minister for Industry and Trade, to its Seoul office on May 19. The Minister’s visit highlights a deepening collaboration between South Korea and Australia in the field of clinical research and highlights the strategic importance of cross-border partnerships in advancing global drug development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527294947/en/ Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong,

LambdaTest Introduces Automation MCP Server to Revolutionize Test Failure Triaging27.5.2025 17:00:00 CEST | Press release

~New server connects AI assistants directly to test execution data, streamlining debugging and accelerating development~ LambdaTest, a unified agentic AI and cloud engineering platform, has announced the launch of its Automation MCP Server, a breakthrough solution designed to simplify and accelerate the process of triaging test failures. By enabling direct integration between AI assistants and LambdaTest’s test execution data, the Automation MCP Server empowers developers and QA engineers to investigate and resolve issues faster, without leaving their integrated development environment (IDE). The Automation MCP Server offers a seamless interface within the IDE, allowing users to access and analyze real-time test data with ease. With intelligent root cause analysis, the MCP server can quickly identify the underlying reasons for test failures and take immediate action to fix the underlying code. This results in fewer debugging cycles and faster release times. The server also enhances aut

The Six Winning Projects of the 12th Edition of the IBSA Foundation Fellowships have been Awarded and the 2025 Call is Now Open27.5.2025 16:58:00 CEST | Press release

The winners of the 2024 IBSA Foundation Fellowships Call come from two US, two Swedish, one Italian and one British universities.This year’s edition set a new record: 259 projects submitted from 45 countries.The awards ceremony was held today in Milan; during the event, the 2025 call for applications was officially opened. Research means investing in the future. This is the guiding principle behind the IBSA Foundation Fellowships programme, which for over a decade has supported talented researchers under 40 from universities and research institutions around the world. The programme awards grants to promote innovative and potentially groundbreaking projects in lesser-explored scientific fields; a constantly growing success, also confirmed by the 2024 edition, which marked a new record, with 259 applications across five scientific areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250522244202/en/ The Award Ceremony of the

Rigaku Completes New Building at Yamanashi Plant27.5.2025 16:00:00 CEST | Press release

Dramatic 2.7-fold increase in floor space to serve global demand Rigaku Corporation, a global solution partner in X-ray analytical technologies and a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; President and CEO: Jun Kawakami; hereinafter “Rigaku”) completed an additional manufacturing building (hereinafter “the New Building”) at Yamanashi Plant, Rigaku’s main production facility. The facility was established to serve as the center of Rigaku’s production framework, in anticipation of global business growth and expansion in product demand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527974928/en/ Exterior view of the New Building, Yamanashi Plant Doubling of production capacity: a strategic base to support Rigaku’s growth Demand for X-ray analytical solutions has soared in recent years, both in Japan and worldwide. To respond to growing demand, Rigaku implemented this expansion with two

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye